News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
FDA Accused St. Jude Medical of Violating the Law by Marketing Ablation Devices Without Federal Approval
May 11, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WSJ -- The Food and Drug Administration accused medical-device maker St. Jude Medical Inc. of violating the law by promoting and marketing its Epicor "surgical ablation" devices to treat a common heart-rhythm disorder without federal approval.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
IN PARTNERSHIP WITH ELEMENT
Pharma Faces Investor Woes and Tariff Threats, Turns to AI and Collaboration for Survival
November 3, 2025
·
5 min read
·
BioSpace Insights
Gene editing
FDA Eyes Accelerated Reviews for Gene Editing Therapies
November 3, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Life-Threatening Liver Toxicity Triggers FDA Freeze on Two Intellia Gene Therapy Studies
October 30, 2025
·
2 min read
·
Tristan Manalac
Podcast
Novartis’ Big Buy, Q3 Earnings, Regeneron’s Dropped Cell Therapy, More
October 29, 2025
·
1 min read
·
Heather McKenzie